SYP and neuroendocrine carcinoma: Additionally, the neuroendocrine chromogranin A and synaptophysin markers were diffusely expressed in C1022 primary tumor and PDX, supporting the diagnosis of poorly differentiated neuroendocrine carcinoma (Supplementary Figure 5).